The Centers for Medicare & Medicaid Services has announced the selection of 15 prescription drugs for the third cycle of the ...
Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...
CMS names medications 2028 for Medicare price negotiation, including Trulicity and Biktarvy, targeting high-cost drugs in ...
The selected medications treat a range of conditions, including cancer, psoriatic arthritis, and human immunodeficiency virus ...
The Centers for Medicare & Medicaid Services yesterday announced 15 drugs under Medicare Parts D and B selected for the third round of price negotiations. Negotiations will occur this year and any ...
Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...
Still, the medications in the latest round of negotiations — which now includes “Part B” drugs given in doctors offices — ...
The Centers for Medicare & Medicaid Services (CMS) released a list of prescription drugs it hopes to include in its new Medicare $2 Drug List Model, the agency announced Wednesday. Designed to limit ...
The Medicare Inpatient Only (IPO) list details the procedures that Medicare will cover in an inpatient setting. The Centers for Medicare & Medicaid Services (CMS) releases the IPO list each year. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results